Dovitinib lactate: Preliminary Phase I/II data

Preliminary data from 11 patients in a Phase I/II trial showed that oral Dovitinib lactate (TKI258) produced 1 partial response and 4 cases of stable disease. There were 2 dose-limiting toxicities of ...